Loading people...
Alexander Demoulin is a Principal at Bioqube Ventures based in Belgium, where he specializes in early-stage life sciences and biotechnology investments. Since joining the firm in 2017, he has focused on deal sourcing, due diligence, portfolio support, and new venture creation for biotech therapeutics. Prior to his current role, Demoulin managed the JLINX incubation and investment model in partnership with J&J Innovation. He additionally serves as an Advisor to the BioInnovation Institute Venture House and is an active member of the YVC Collective. His academic credentials include a Master of Science in Medical Biotechnology and Business Management from the University of Warwick and a Bachelor in Biomedical Sciences from Antwerp University. Demoulin's professional focus remains on identifying, funding, and scaling early-stage therapeutic technologies across the European venture capital ecosystem.
Alexander Demoulin is a key member of the investment team at Bioqube Ventures, where he holds the position of Associate. Bioqube Ventures is renowned for its strategic investments in the life sciences sector, focusing on early-stage companies that are poised to make significant impacts in healthcare. In his role, Alexander is instrumental in the entire investment process, from initial deal sourcing and market analysis to rigorous due diligence and portfolio company support.
His primary investment focus areas align with Bioqube Ventures' mandate, encompassing a broad spectrum of life sciences innovations. This includes cutting-edge biotechnology firms developing novel therapeutics, diagnostics, and platforms. He also has a keen interest in medtech companies that are creating advanced medical devices and digital health solutions that aim to improve patient outcomes and healthcare efficiency. Alexander's expertise helps the firm identify promising ventures with strong scientific foundations and viable commercial potential.
Alexander's career background is rooted in a deep understanding of the scientific and financial landscapes relevant to venture capital. Associates in firms like Bioqube Ventures often bring a blend of scientific acumen, analytical skills, and business insight, which is critical for evaluating complex scientific proposals and market opportunities. His work involves comprehensive research into emerging scientific trends, competitive landscapes, and regulatory pathways, ensuring that Bioqube Ventures makes informed investment decisions.
While specific notable investments are often part of a firm's collective portfolio, Alexander's contributions are vital to the success of Bioqube Ventures' overall strategy. He actively engages with founders and scientific teams, assessing their technologies, business models, and management capabilities. His involvement helps shape the firm's investment thesis and supports the growth of portfolio companies, guiding them through critical development stages. Alexander Demoulin's dedication to fostering innovation in life sciences underscores Bioqube Ventures' commitment to advancing healthcare through strategic early-stage investments.
Alexander Demoulin is an Associate at Bioqube Ventures, a leading investment firm focused on the life sciences sector. He plays a key role in identifying and evaluating early-stage investment opportunities.
Alexander Demoulin focuses on early-stage investments within the life sciences, including biotechnology, medtech, and digital health companies that are developing innovative solutions for healthcare.
Alexander Demoulin works at Bioqube Ventures, an investment firm specializing in early-stage life sciences companies.
